May 20, 2020
Boehringer projects good animal health sales to Brazil livestock industry
The Brazil Boehringer Ingelheim's animal health division said the COVID-19 pandemic has slowed demand for veterinary medical products in country, but projects good sales for the major global meat producer and supplier,reported Reuters.
Fabio Barone, Boehringer's animal health business head in Brazil said in 2019, Brazil's animal health market reported a 10% growth, two times higher compared to global numbers.
While he estimated that the animal health market growth will slow down, prospects look good for the livestock market. He did not provide an exact projection.
Brazil is the biggest exporter of beef and chicken in the world.
He said there are big opportunities from a meat exporter's point of view.
Boehringer's Brazil animal health division sales is 60% towards the country's livestock market and 40% to the domestic pet market.
Boehringer's global sales was reported at 20 billion EUR (~US$21.8 million; 1 EUR = US$1.09), with 21% accounted for its animal health division.
Barone said Brazil is one of the company's top 10 markets but did not disclose veterinary product sales in the country.
Boehringer's vaccines and anti-parasitic medicines are produced in Paulínia, São Paulo state. None of its 500 workers have been diagnosed with COVID-19 and the plant has not been ordered to shut down due to the pandemic. Barone said there have been no supply chain breakdowns.